BioXcel Therapeutics Inc (NASDAQ: BTAI) kicked off on Monday, down -6.02% from the previous trading day, before settling in for the closing price of $1.66. Over the past 52 weeks, BTAI has traded in a range of $1.17-$9.26.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 6.20%. While this was happening, its average annual earnings per share was recorded 72.31%. With a float of $21.02 million, this company’s outstanding shares have now reached $21.87 million.
BioXcel Therapeutics Inc (BTAI) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of BioXcel Therapeutics Inc is 3.89%, while institutional ownership is 10.78%.
BioXcel Therapeutics Inc (BTAI) Latest Financial update
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -3.56 earnings per share (EPS), higher than consensus estimate (set at -5.14) by 1.58. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.72 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 72.31% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 55.37% during the next five years compared to 6.20% growth over the previous five years of trading.
BioXcel Therapeutics Inc (NASDAQ: BTAI) Trading Performance Indicators
Take a look at BioXcel Therapeutics Inc’s (BTAI) current performance indicators. Last quarter, stock had a quick ratio of 1.16. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 45.48.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -9.70, a number that is poised to hit -0.84 in the next quarter and is forecasted to reach -3.04 in one year’s time.
Technical Analysis of BioXcel Therapeutics Inc (BTAI)
The latest stats from [BioXcel Therapeutics Inc, BTAI] show that its last 5-days average volume of 0.41 million was inferior to 3.88 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 6.16%.
During the past 100 days, BioXcel Therapeutics Inc’s (BTAI) raw stochastic average was set at 0.46%, which indicates a significant decrease from 2.61% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1227 in the past 14 days, which was lower than the 0.3611 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.9550, while its 200-day Moving Average is $2.3005. Now, the first resistance to watch is $1.6266. This is followed by the second major resistance level at $1.6932. The third major resistance level sits at $1.7364. If the price goes on to break the first support level at $1.5168, it is likely to go to the next support level at $1.4736. The third support level lies at $1.4070 if the price breaches the second support level.
BioXcel Therapeutics Inc (NASDAQ: BTAI) Key Stats
The company with the Market Capitalisation of 34.11 million has total of 21,869K Shares Outstanding. Its annual sales at the moment are 2,270 K in contrast with the sum of -59,600 K annual income. Company’s last quarter sales were recorded 100 K and last quarter income was -30,910 K.
